An industry analyst recently highlighted these six companies in a research note.
News & Features
A successor has not yet been named and it is expected that Gottlieb will leave the position sometime next month.
Many industry stakeholders took to Twitter on Tuesday to respond to the news that FDA Commissioner Scott Gottlieb is stepping down.
New research shows that an engineered model of human liver tissue can be used to investigate the effects of RNAi, helping to speed up the development of such treatments.
Parsippany-Troy Hills, NJ-based Pacira Pharmaceuticals to pay up to $120 million cash up front and an additional $100 million upon the achievement of milestones under the terms of the deal.
Yann Fleureau, co-founder and CEO of Cardiologs, weighs in on why 2019 will be known as the year of validation for artificial intelligence.
The company said the pause in sales was temporary and that it was not related to the performance and safety of Recell.
The FlexArm gantry enables clinicians to quickly and easily visualize critical anatomy and identify changes to a patient during a procedure.
A study looked at surgical work flow to better understand how Unique Device Identifiers are recorded.
These were some of the most thought-provoking comments MD+DI editors heard from industry experts who spoke at MD&M West 2019.